Pmv Pharmaceuticals Inc (PMVP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | ||
| Net Income | -25,352 | -17,538 |
| Depreciation Amortization | 450 | 657 |
| Other Working Capital | 1,921 | 637 |
| Other Operating Activity | 916 | 1,066 |
| Operating Cash Flow | $-22,065 | $-15,178 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -109 | -452 |
| Other Investing Activity | 3,340 | 22,145 |
| Investing Cash Flow | $3,231 | $21,693 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 61,805 | 0 |
| Financing Cash Flow | $61,805 | $0 |
| Beginning Cash Position | 30,307 | 23,792 |
| End Cash Position | 73,278 | 30,307 |
| Net Cash Flow | $42,971 | $6,515 |
| Free Cash Flow | ||
| Operating Cash Flow | -22,065 | -15,178 |
| Free Cash Flow | -22,065 | -15,178 |